GliSODin (Superoxide Dismutase / Melon Extract) — Supplements
Patented oral superoxide dismutase supplement combining melon-derived SOD with wheat gliadin for acid-stable bioavailability, with 30+ clinical publications demonstrating antioxidant, skin-protective, and anti-inflammatory effects.
Overview
GliSODin is a patented nutraceutical combining superoxide dismutase (SOD) extracted from a specific Cucumis melo (cantaloupe melon) cultivar with wheat gliadin biopolymer coating. Standard oral SOD is destroyed by gastric acid and digestive proteases, rendering it inactive. The gliadin matrix protects SOD through the stomach and releases it progressively in the intestine, enabling systemic absorption and upregulation of endogenous antioxidant enzymes (SOD, catalase, glutathione peroxidase). SOD neutralizes superoxide radicals at a catalytic ratio of 1:1,000,000 — compared to 1:1 for stoichiometric antioxidants like vitamins C and E. Over 30 scientific publications spanning 15+ years validate GliSODin across multiple clinical domains. A 50-participant RCT showed 500 mg/day for 4 weeks significantly increased UV tolerance before erythema onset. A 6-month double-blind RCT (n=50) in vitiligo patients demonstrated 50% greater repigmentation when GliSODin was combined with narrowband UVB phototherapy versus UVB alone. In elite rowers, 500 mg/day for 6 weeks reduced creatine kinase, CRP, and IL-6 while improving power output at lactate threshold. A 2022 double-blind RCT (n=46 women, 50-80 years) showed improvement in locomotive syndrome symptoms (knee and lower back pain) over 6 months at 500 mg/day. Additional evidence exists for cardiovascular protection (reduced carotid intima-media thickness), cognitive preservation (maintained hippocampal neurogenesis under stress), and NASH prevention in preclinical models.
Indications
- Endogenous antioxidant enzyme upregulation (SOD, catalase, GPx)
- UV photoprotection and skin aging prevention
- Vitiligo (adjunct to phototherapy — 50% improved repigmentation)
- Athletic recovery and exercise-induced oxidative stress reduction
- Joint and musculoskeletal health (locomotive syndrome)
- Skin hyperpigmentation and erythema reduction
- Cardiovascular oxidative stress reduction
Mechanism of Action
Wheat gliadin biopolymer forms an acid-resistant matrix around melon-derived SOD, surviving gastric digestion and releasing active enzyme in the intestinal lumen for absorption
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| GliSODin | 500 mg (2 capsules) | Once daily | Standard dose for general antioxidant support; take on empty stomach |
| GliSODin (Vitiligo Protocol) | 1,000 mg (4 capsules) months 1-3, then 500 mg months 4-6 | Once daily | Combined with narrowband UVB phototherapy; first results ~3 months, optimal at 6 months |
| GliSODin (Athletic Performance) | 500 mg | Once daily, 1 hour pre-training | Minimum 6-week loading period for measurable recovery benefit |
| GliSODin (Locomotive Syndrome) | 500 mg (6 capsules of specific formulation) | Once daily before breakfast | 6-month protocol for knee and lower back symptom improvement |
Safety & Contraindications
- Contains wheat gliadin — CONTRAINDICATED in celiac disease, wheat allergy, and non-celiac gluten sensitivity
- No adverse effects reported in a 2-year safety study (n=16)
- Generally well-tolerated across all clinical trials
- Consult physician if pregnant or breastfeeding
- May interact with immunosuppressive medications due to immune-modulatory effects
- Newer gliadin-free formulations (V-SOD) are available for gluten-sensitive individuals — verify product label